|This article's lead section may not adequately summarize key points of its contents. (December 2012)|
- 1 Glutamic acid versus glutamate
- 2 Discovery
- 3 Isomers
- 4 Taste perception
- 5 Sources
- 6 Safety as a flavor enhancer
- 7 Regulations
- 8 Ingredients
- 9 See also
- 10 Notes
- 11 References
Glutamic acid versus glutamate
When glutamic acid or one of its salts is dissolved in aqueous solutions, a pH-dependent instantaneous chemical equilibrium of the amino acid's ionized forms, including zwitterionic forms, will result. These ions are called glutamates. Salts exist only in a dry and crystallized form. The form ultimately responsible for the taste is the glutamate ion, and the form of glutamic acid at the time of the addition is not important. However, crystalline glutamic acid salts such as monosodium glutamate dissolve much better and faster than crystalline glutamic acid, a property important for use as a flavor enhancer.
Although they occur naturally in many foods, the flavor contributions made by glutamic acid and other amino acids were only scientifically identified early in the twentieth century. The substance was discovered and identified in the year 1866, by the German chemist Karl Heinrich Ritthausen. In 1907 Japanese researcher Kikunae Ikeda of the Tokyo Imperial University identified brown crystals left behind after the evaporation of a large amount of kombu broth as glutamic acid. These crystals, when tasted, reproduced the ineffable but undeniable flavor he detected in many foods, most especially in seaweed. Professor Ikeda termed this flavor umami. He then patented a method of mass-producing a crystalline salt of glutamic acid, monosodium glutamate.
Only the L-glutamate enantiomer has flavor-enhancing properties. Manufactured monosodium glutamate contains over 99.6% of the naturally-predominant L-glutamate form, which is a higher proportion of L-glutamate than found in the free glutamate ions of fermented naturally-occurring foods. Fermented products such as soy sauce, steak sauce, and Worcestershire sauce have levels of glutamate similar to foods with added monosodium glutamate. However, 5% or more of the glutamate may be the D-enantiomer. Nonfermented naturally-occurring foods have lower relative levels of D-glutamate than fermented products.
Glutamic acid stimulates specific receptors located in taste buds such as the amino acid receptor T1R1/T1R3 or other glutamate receptors like the metabotropic receptors (mGluR4 and mGluR1) which induce the taste known as umami, one of the five basic tastes (the word umami is a loanword from Japanese; it is also referred to as "savory" or "meaty").
Glutamate itself is a widespread amino acid. It is found naturally in all living cells, primarily in the bound form as part of proteins. Only a fraction of the glutamate in foods is in its "free" form, and only free glutamate can enhance the flavor of foods. Part of the flavor-enhancing effect of tomatoes, fermented soy products, yeast extracts, certain sharp cheeses, and fermented or hydrolyzed protein products (such as soy sauce and fermented bean paste) is due to the presence of free glutamate ions.
Japanese cuisine originally used broth made from kombu (kelp) to bring up the umami taste in soups. Manufacturers, such as Ajinomoto, use selected strains of Micrococcus glutamicus bacteria in a nutrient-rich medium. The bacteria are selected for their ability to excrete glutamic acid, which is then separated from the nutrient medium and processed into its sodium salt, monosodium glutamate.
In the Roman Empire glutamic acid was found in a sauce called garum, made from fermenting fish in saltwater. The flavor enhancing properties of glutamic acid allowed Romans to reduce the use of expensive salt.
Concentration in foods
|Food||Free glutamate (mg/100 g)||Protein glutamate (mg/100 g)|
|Rausu kombu (kelp)||2286|
|Rishiri kombu (kelp)||1985|
|Hidaka kombu (kelp)||1344|
|Japanese fish sauce||1383|
|Korean soy sauce||1264|
|Chinese soy sauce||926|
|Japanese soy sauce||782|
Hydrolyzed proteins, or protein hydrolysates, are acid- or enzymatically treated proteins from certain foods. One example is yeast extract. Hydrolyzed protein contains free amino acids, such as glutamate, at levels of 5% to 20%. Hydrolyzed protein is used in the same manner as monosodium glutamate in many foods, such as canned vegetables, soups, and processed meats.
Safety as a flavor enhancer
In April 1968, Robert Ho Man Kwok wrote a letter to the New England Journal of Medicine, coining the term "Chinese restaurant syndrome". In this letter he claimed:
I have experienced a strange syndrome whenever I have eaten out in a Chinese restaurant, especially one that served northern Chinese food. The syndrome, which usually begins 15 to 20 minutes after I have eaten the first dish, lasts for about two hours, without hangover effect. The most prominent symptoms are numbness at the back of the neck, gradually radiating to both arms and the back, general weakness and palpitations...
The syndrome is often abbreviated as CRS and also became known under the names "Chinese food syndrome" and "monosodium glutamate symptom complex."
Symptoms attributed to the Chinese restaurant syndrome are rather common and unspecific.
Although many people believe that monosodium glutamate (MSG) is the cause of these symptoms, an association has never been demonstrated under rigorously controlled conditions, even in studies with people who were convinced that they were sensitive to the compound. Techniques used to adequately control for experimental bias include a placebo-controlled double-blinded experimental design and the use of capsules to deliver the compound to mask the strong and unique after-taste of glutamates.
In 1959, the U.S. Food and Drug Administration (FDA) classified monosodium glutamate as generally recognized as safe (GRAS). This action stemmed from the 1958 Food Additives Amendment to the Federal Food, Drug, and Cosmetic Act that required premarket approval for new food additives and led the FDA to promulgate regulations listing substances, such as monosodium glutamate, which have a history of safe use or are otherwise GRAS.
Since 1970, FDA has sponsored extensive reviews on the safety of monosodium glutamate, other glutamates, and hydrolyzed proteins, as part of an ongoing review of safety data on GRAS substances used in processed foods. One such review was by the Federation of American Societies for Experimental Biology (FASEB) Select Committee on GRAS Substances. In 1980, the committee concluded that monosodium glutamate was safe at current levels of use but recommended additional evaluation to determine monosodium glutamate's safety at significantly higher levels of consumption. Additional reports attempted to look at this.
In 1986, FDA's Advisory Committee on Hypersensitivity to Food Constituents concluded that monosodium glutamate poses no threat to the general public but that reactions of brief duration might occur in some people. Other reports have given the following findings:
- The 1987 Joint Expert Committee on Food Additives of the United Nations Food and Agriculture Organization and the World Health Organization placed monosodium glutamate in the safest category of food ingredients.
- A 1991 report by the European Community's (EC) Scientific Committee for Foods reaffirmed monosodium glutamate's safety and classified its "acceptable daily intake" as "not specified", the most favorable designation for a food ingredient. In addition, the EC Committee said, "Infants, including prematures, have been shown to metabolize glutamate as efficiently as adults and therefore do not display any special susceptibility to elevated oral intakes of glutamate." Legislation in effect since June 2013 classifies glutamic acid and glutamates as salt substitutes and seasonings and condiments with a maximum level of consumption of 10g/kg expressed as glutamic acid.
Because glutamate is absorbed very quickly in the gastrointestinal tract (unlike glutamic acid-containing proteins in foods), glutamate could spike blood plasma levels of glutamate. Glutamic acid is in a class of chemicals known as excitotoxins, high levels of which have been shown in animal studies to cause damage to areas of the brain unprotected by the blood–brain barrier and that a variety of chronic diseases can arise out of this neurotoxicity. There has been debate among scientists on the significance of these findings since the early 1970s, when John Olney found that high levels of glutamic acid caused damage to the brains of infant mice. The debate is complex and has focused mainly on whether the increase in plasma glutamate levels from typical ingestion levels of glutamate is enough to cause neurotoxicity and on whether humans are susceptible to the neurotoxicity from glutamic acid seen in some animal experiments.
At a meeting of the Society for Neuroscience in 1990, the delegates had a split opinion on the issues related to neurotoxic effects from excitotoxic amino acids found in some additives such as monosodium glutamate.
Some scientists believe that humans and other primates are not as susceptible to excitotoxins as rodents and therefore there is little concern with glutamic acid as a food additive. While they agree that the combined effects of all food-based excitotoxins should be considered, their measurements of the blood plasma levels of glutamic acid after ingestion of monosodium glutamate and aspartame demonstrate that there is not a cause for concern.
Olney, a longtime campaigner for greater regulation of MSG, believes that primates are susceptible to excitotoxic damage, and other studies have shown that humans concentrate excitotoxins in the blood more than other animals. Based on these findings, Olney claims that humans are approximately 5–6 times more susceptible to the effects of excitotoxins than rodents are. While he agrees that typical use of monosodium glutamate does not spike glutamic acid to extremely high levels in adults, he is particularly concerned with potential effects in infants and young children and the potential long-term neurodegenerative effects of small-to-moderate spikes on plasma excitotoxin levels.
Following the compulsory EU-food labeling law the use of glutamic acid and its salts has to be declared, and the name or E number of the salt has to be listed. Glutamic acid and its salts as food additives have the following E numbers: glutamic acid: E620, monosodium glutamate: E621, monopotassium glutamate: E622, calcium diglutamate: E623, monoammonium glutamate: E624, and magnesium diglutamate: E625. In the European Union, these enhancers are not allowed to be added to milk, emulsified fat and oil, pasta, cocoa/chocolate products and fruit juice. The EU did not yet publish an official NOAEL (no observable adverse effect level) for glutamate, but a 2006 consensus statement of a group of German experts drawing from animal studies was that a daily intake of glutamic acid of 6 grams per kilogram of body weight (6 g/kg/day) is safe. From human studies, the experts noted that doses as high as 147 g/day produced no adverse effects in males when given for 30 days; in a 70 kg male that corresponds to 2.1 g per kg of body weight.
In 1959, the Food and Drug Administration classified MSG as a "generally recognized as safe" (GRAS) food ingredient under the Federal Food, Drug, and Cosmetic Act. In 1986, FDA's Advisory Committee on Hypersensitivity to Food Constituents also found that MSG was generally safe, but that short-term reactions may occur in some people. To further investigate this matter, in 1992 the FDA contracted the Federation of American Societies for Experimental Biology (FASEB) to produce a detailed report, which was published in 1995. The FASEB report reaffirmed the safety of MSG when it is consumed at usual levels by the general population, and found no evidence of any connection between MSG and any serious long-term reactions.
Under 2003 U.S. Food and Drug Administration regulations, when monosodium glutamate is added to a food, it must be identified as "monosodium glutamate" in the label's ingredient list. Because glutamate is commonly found in food, primarily from protein sources, the FDA does not require foods and ingredients that contain glutamate as an inherent component to list it on the label. Examples include tomatoes, cheeses, meats, hydrolyzed protein products such as soy sauce, and autolyzed yeast extracts. These ingredients are to be declared on the label by their common or usual names. The term 'natural flavor' is now used by the food industry when using glutamic acid. Because of lack of regulation, it is impossible to determine what percentage of 'natural flavor' is actually glutamic acid.
The food additives disodium inosinate and disodium guanylate are usually used in synergy with monosodium glutamate-containing ingredients, and provide a likely indicator of the addition of glutamate to a product.
Australia and New Zealand
Standard 1.2.4 of the Australia New Zealand Food Standards Code requires the presence of monosodium glutamate as a food additive to be labeled. The label must bear the food additive class name (e.g. flavor enhancer), followed by either the name of the food additive (e.g. MSG) or its International Numbering System (INS) number (e.g. 621)
The Canada Food Inspection Agency considers claims of "no MSG" or "MSG free" to be misleading and deceptive when other sources of free glutamates are present.
Food ingredients that contain glutamic acid include:
- Hydrolyzed vegetable protein
- Autolyzed yeast, yeast extract, yeast food, and yeast nutrient
- Glutamic acid (E620), glutamate (E620)
- Monopotassium glutamate (E622)
- Calcium glutamate (E623)
- Monoammonium glutamate (E624)
- Magnesium glutamate (E625)
- Sodium glutamate (E621)
- Renton, Alex (2005-07-10). "If MSG is so bad for you, why doesn't everyone in Asia have a headache?". The Guardian. Retrieved 2008-11-21.
- "Kikunae Ikeda Sodium Glutamate". Japan Patent Office. 2002-10-07. Retrieved 2008-11-21.
- Rundlett KL, Armstrong DW (1994). "Evaluation of free D-glutamate in processed foods". Chirality. 6 (4): 277–82. doi:10.1002/chir.530060410. PMID 7915127.
- Rossella Lorenzi (Sep 29, 2008). "Fish Sauce Used to Date Pompeii Eruption". Discovery News.
- K. Kris Hirst. "Roman Empire Fish Sauce Garum".
- "Sodium Glutamate: A Safety Assessment" (PDF). Food Standards Australia New Zealand. June 2003. Retrieved 2016-01-11.
- "Umami Information Center". Retrieved 2012-02-02.
- Robert Ho Man Kwok (1968). "Chinese restaurant syndrome". N. Engl. J. Med. 18 (178): 796. doi:10.1056/nejm196804042781419.
- Tarasoff L.; Kelly M.F. (1993). "Monosodium L-glutamate: a double-blind study and review". Food Chem. Toxicol. 31 (12): 1019–1035. doi:10.1016/0278-6915(93)90012-N. PMID 8282275.
- Freeman M. (October 2006). "Reconsidering the effects of monosodium glutamate: a literature review". J Am Acad Nurse Pract. 18 (10): 482–6. doi:10.1111/j.1745-7599.2006.00160.x. PMID 16999713.
- Rosenblaum I.; Bradley J.; Coulston F. (February 1971). "Single and double blind studies with oral monosodium glutamate in man". Toxicology and Applied Pharmacology. 18 (2): 367–373. doi:10.1016/0041-008X(71)90129-3.
- "Database of Select Committee on GRAS Substances (SCOGS) Reviews". U.S. Food and Drug Administration. Archived from the original on May 21, 2007. Retrieved 2008-03-22.
- European Community. "Food Additives Database". DG Sanco, Bruxelles.
- "COMMISSION REGULATION (EU) No 1129/2011". European Community.
- Stegink LD, Filer LJ Jr, Baker GL (1985). "Plasma glutamate concentrations in adult subjects ingesting monosodium L-glutamate in consomme". American Journal of Clinical Nutrition. 42 (2): 220–225. PMID 2862786.
- Stegink LD, Filer LJ Jr, Baker GL (1987). "Plasma amino acid concentrations in normal adults ingesting aspartame and monosodium L-glutamate as part of a soup/beverage meal". Metabolism. 36 (11): 1073–1079. doi:10.1016/0026-0495(87)90028-X. PMID 3670074.
- Himwich WA, Petersen IM (1954). "Ingested sodium glutamate and plasma levels of glutamic acid". Journal of Applied Physiology. 7 (2): 196–199. PMID 13211498.
- Meldrum B (1993). "Amino acids as dietary excitotoxins: a contribution to understanding neurodegenerative disorders". Brain research. Brain research reviews. 18 (3): 293–314. doi:10.1016/0165-0173(93)90014-Q. PMID 8401596.
- Nemeroff C, Miller Sanford A (ed.) (1980). "Monosodium Glutamate-induced neurotoxicity: Review of the literature and call for further research". Nutrition & Behavior (U.S. Food & Drug Administration): 177–211.
- Olney JW, Ho OL (1970). "Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine". Nature. 227 (5258): 609–611. doi:10.1038/227609b0. PMID 5464249.
- Barinaga, M (1990). "Amino acids: How much excitement is too much?". Science. 247 (4938): 20–22. doi:10.1126/science.2294587. PMID 2294587.
- Abraham R, Swart J, Golberg L, Coulston F (1975). "Electron microscopic observations of hypothalami in neonatal rhesus monkeys (Macaca mulatta) after administration of monosodium-L-glutamate". Experimental and molecular pathology. 23 (2): 203–213. doi:10.1016/0014-4800(75)90018-0. PMID 810365.
- Reynolds WA, Butler V, Lemkey-Johnston N (1976). "Hypothalamic morphology following ingestion of aspartame or MSG in the neonatal rodent and primate: a preliminary report". Journal of Toxicology and Environmental Health. 2 (2): 471–480. doi:10.1080/15287397609529448. PMID 827619.
- Stegink LD, Filer LJ Jr, Baker GL (1982). "Effect of aspartame plus monosodium L-glutamate ingestion on plasma and erythrocyte amino acid levels in normal adult subjects fed a high protein meal". American Journal of Clinical Nutrition. 36 (6): 1145–1152. PMID 7148735.
- Stegink LD, Filer LJ Jr, Baker GL (1982). "Plasma and erythrocyte amino acid levels in normal adult subjects fed a high protein meal with and without added monosodium glutamate". Journal of Nutrition. 112 (10): 1953–1160. PMID 7119898.
- Olney JW, Sharpe LG, Feigin RD (1972). "Glutamate-induced brain damage in infant primates". Journal of Neuropathology and Experimental Neurology. 31 (3): 464–488. doi:10.1097/00005072-197207000-00006. PMID 4626680.
- Stegink LD, et al. (1978). "Comparative metabolism of glutamate in the mouse, monkey, and man". Glutamic Acid: Advances in Biochemistry and Physiology (Edited: Filer LJ): 85–102.
- Olney JW (1984). "Excitotoxic food additives — relevance of animal studies to human safety". Neurobehavioral toxicology and teratology. 6 (6): 455–462. PMID 6152304.
- Olney JW (1990). "Excitotoxin-mediated neuron death in youth and old age". Progress in brain research. Progress in Brain Research. 86: 37–51. doi:10.1016/S0079-6123(08)63165-9. ISBN 978-0-444-81121-9. PMID 1982368.
- Olney JW (1994). "Excitotoxins in foods". Neurotoxicology. 15 (3): 535–544. PMID 7854587.
- Beyreuther K, Biesalski HK, Fernstrom JD, et al. (March 2007). "Consensus meeting: monosodium glutamate - an update". Eur J Clin Nutr. 61 (3): 304–13. doi:10.1038/sj.ejcn.1602526. PMID 16957679.
- Meadows Michelle (January–February 2003). "MSG: A common flavor enhancer". FDA Consumer. United States Food and Drug Administration. 37 (1).
- "Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients)". Nap.edu. 2003-06-01. Retrieved 2012-02-16.
- "Canadian Food Inspection Agency - Chapter 4 - Composition, Quality, Quantity and Origin Claims Sections 4.1-4.6". Inspection.gc.ca. 2011-03-03. Retrieved 2015-04-11.
- Jordan Sand, "A Short History of MSG: Good Science, Bad Science, and Taste Cultures", Gastronomica '5':4 (Fall 2005). History of MSG and its marketing in Japan, Taiwan (under the Japanese), China, and the U.S.
- Federal Register, Dec. 4, 1992 (FR 57467)
- Federal Register, Jan. 6, 1993 (FR 2950)
- FDA Consumer, December 1993, "Food Allergies: When Eating is Risky."